260 related articles for article (PubMed ID: 27285519)
21. To inform or persuade? Direct-to-consumer advertising of prescription drugs.
Berndt ER
N Engl J Med; 2005 Jan; 352(4):325-8. PubMed ID: 15673797
[No Abstract] [Full Text] [Related]
22. Drug Advertising Violations: A Longitudinal Trend Analysis of FDA Enforcement Letters from 2005 to 2019.
Zagrodney KAP; Sheikhan NY; Pinto A; Sheikhan T; Witek TJ
Pharmaceut Med; 2021 Jan; 35(1):31-38. PubMed ID: 33453042
[TBL] [Abstract][Full Text] [Related]
23. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
Cowden AL; Katz KA
Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900
[TBL] [Abstract][Full Text] [Related]
24. Direct-to-Consumer Advertising of Prescription Drugs Can Inform the Public and Improve Health.
Adams C
JAMA Oncol; 2016 Nov; 2(11):1395-1396. PubMed ID: 27532690
[No Abstract] [Full Text] [Related]
25. What influences healthcare providers' prescribing decisions? Results from a national survey.
Price SM; O'Donoghue AC; Rizzo L; Sapru S; Aikin KJ
Res Social Adm Pharm; 2021 Oct; 17(10):1770-1779. PubMed ID: 33558154
[TBL] [Abstract][Full Text] [Related]
26. Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Off-Label Promotion and Adherence to FDA Guidelines.
Klara K; Kim J; Ross JS
J Gen Intern Med; 2018 May; 33(5):651-658. PubMed ID: 29484575
[TBL] [Abstract][Full Text] [Related]
27. Prescription Drug Promotion from 2001-2014: Data from the U.S. Food and Drug Administration.
Sullivan HW; Aikin KJ; Chung-Davies E; Wade M
PLoS One; 2016; 11(5):e0155035. PubMed ID: 27149513
[TBL] [Abstract][Full Text] [Related]
28. Which prescription for the illegible and unreadable DTC (direct-to-consumer) brief summary--major surgery or euthanasia?
Hochhauser M
Manag Care Q; 2002; 10(3):6-10. PubMed ID: 12476659
[TBL] [Abstract][Full Text] [Related]
29. FDA weighs limits for online ads.
Kuehn BM
JAMA; 2010 Jan; 303(4):311-3. PubMed ID: 20103748
[No Abstract] [Full Text] [Related]
30. The Food and Drug Administration's regulation of drug labeling, advertising, and promotion: looking back and looking ahead.
Hayes TA
Clin Pharmacol Ther; 1998 Jun; 63(6):607-16. PubMed ID: 9663174
[No Abstract] [Full Text] [Related]
31. How should FDA regulate prescription drug promotion on the Internet?
Opderbeck DW
Food Drug Law J; 1998; 53(1):47-61. PubMed ID: 11795336
[TBL] [Abstract][Full Text] [Related]
32. How the FDA and the ADA affect development of prescription drugs for oral care.
Cooley WE
J Public Health Dent; 1992; 52(6):350-2. PubMed ID: 1432922
[TBL] [Abstract][Full Text] [Related]
33. The promise and peril of direct-to-consumer prescription drug promotion on the Internet.
Hall TS
DePaul J Health Care Law; 2003; 7(1):1-41. PubMed ID: 15468476
[No Abstract] [Full Text] [Related]
34. Direct-to-Consumer Prescription Drug Advertising and Patient-Provider Interactions.
Sullivan HW; Aikin KJ; Berktold J; Stein KL; Hoverman VJ
J Am Board Fam Med; 2020; 33(2):279-283. PubMed ID: 32179611
[TBL] [Abstract][Full Text] [Related]
35. FDA approval of comparative claims for prescription drugs--the Moxam case.
Marcus D
Drug Inf J; 1983; 17(3):171-5. PubMed ID: 10265094
[TBL] [Abstract][Full Text] [Related]
36. Direct-to-consumer prescription drug advertising.
Terzian TV
Am J Law Med; 1999; 25(1):149-67. PubMed ID: 10207573
[No Abstract] [Full Text] [Related]
37. The Vernacular of Risk--Rethinking Direct-to-Consumer Advertising of Pharmaceuticals.
Greene JA; Watkins ES
N Engl J Med; 2015 Sep; 373(12):1087-9. PubMed ID: 26287749
[No Abstract] [Full Text] [Related]
38. Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay.
Aikin KJ; Southwell BG; Paquin RS; Rupert DJ; O'Donoghue AC; Betts KR; Lee PK
Res Social Adm Pharm; 2017; 13(2):378-388. PubMed ID: 27178746
[TBL] [Abstract][Full Text] [Related]
39. Origins of the prohibition against off-label promotion.
Coleman TS
Food Drug Law J; 2014; 69(2):161-236, i. PubMed ID: 25163210
[TBL] [Abstract][Full Text] [Related]
40. The Food and Drug Administration's regulation of prescription drug manufacturer speech: a First Amendment analysis.
Evans GW; Friede AI;
Food Drug Law J; 2003; 58(3):365-437. PubMed ID: 14626984
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
